Colorectal cancer screening program in Poland pathologists - - PowerPoint PPT Presentation

colorectal cancer screening program in poland pathologist
SMART_READER_LITE
LIVE PREVIEW

Colorectal cancer screening program in Poland pathologists - - PowerPoint PPT Presentation

Colorectal cancer screening program in Poland pathologists perspective Andrzej Mrz Department of Gastroenterology, Hepatology and Clinical Oncology Medical Center of Postgraduate Education Warsaw Poland Visegrad 27.05.2017, Hungary


slide-1
SLIDE 1

Colorectal cancer screening program in Poland – pathologist’s perspective

Andrzej Mróz Department of Gastroenterology, Hepatology and Clinical Oncology Medical Center of Postgraduate Education Warsaw Poland Visegrad 27.05.2017, Hungary

slide-2
SLIDE 2

WHO: Screening programs

  • 1. Common disease with high mortality
  • 2. Possible detection of precursor lesions or

asymptomatic illness

  • 3. Early detection improves prognosis
  • 4. Socially acceptable
  • 5. Cost effective

Wilson JMG, WHO, 1968

slide-3
SLIDE 3

Malignant tumors in Poland

Lung cancer Colorectal cancer Breast cancer

Wojciechowska i wsp. Nowotwory złośliwe w Polsce w 2010 roku, KRN

slide-4
SLIDE 4

Dynamics of colorectal cancer incidence

Colorectal cancer Lung cancer Males Females

Incidence Incidence

y 90’ 95’ 00’ 05’ y 90’ 95’ 00’ 05’

slide-5
SLIDE 5

Cancer develops from polyps (adenomas)

> > >

adenoma

> > > > >

CA >>

Duration: 7 - 12 YEARS

slide-6
SLIDE 6

5 year survivals ratios in CRC

diagnosis 2000

Europe: 53,5% Poland: 43,7%

Berrino F, et al. Lancet Oncol 2007 Krajowy Rejestr Nowotowrów, COI

slide-7
SLIDE 7

CRC screening program in Poland

Method:

screening colonoscopy

  • pportunistic program till 2011

+ invitations based since 2012

Start:

2000

Priorities:

quality control trainings of doctors/centers

  • ptimalization
slide-8
SLIDE 8

Why colonoscopy in Poland?

  • The only one step strategy
  • Simple organization: once every 10 years
  • Not expensive: ca.120 euro

per/procedure (5 rounds of FOBT)

  • FOBT acceptance (80-ties) - 16%
slide-9
SLIDE 9

Efficacy of population screening programs in RCT

FOBT

  • CRC mortality reduction: 0,86 (95%CI 0,80-0,92)

Sigmoidoscopy

  • CRC mortality reduction: 0,72 (95%CI 0,65-0,79)
  • CRC mortality reduction: 0,77 (95%CI 0,70-0,84)

Colonoscopy

  • Probably ≥ Sigmoidoscopy

Holme O, et al. Cochrane Database Syst Rev, 2013

slide-10
SLIDE 10

Expected results in 2026 !

Kaminski MF, et al. Endoscopy, 2012

slide-11
SLIDE 11

Opportunistic program, 2000-11

320 000 screening colonoscopies

92 centers in 2011

slide-12
SLIDE 12

Invitations based screening program

slide-13
SLIDE 13
slide-14
SLIDE 14

High Quality Histopathology

Unification of reports Pathologic report in categorization Linked to central database (as a

incoherent part)

Trainings Adenoma detection rate – checked by

pathologists as endoscopist and screening quality indicator

slide-15
SLIDE 15

Histopathological report

Histological type Architecture Grade of dysplasia Completeness of resection

Adenoma

slide-16
SLIDE 16

Reporting challenges

Grade of dysplasia – some of pathologists

are used to three tier classification

No proforma required Completeness of excision reporting –

restrictive way, limited contact with the clinician

slide-17
SLIDE 17

Completeness of excision

slide-18
SLIDE 18

HGD in adenomas EGuide

7.21- Pathologists reporting in a

colonoscopy screening programme should not report high-grade neoplasia in more than 5% of lesions and those in an FOBT programme in not more than 10% of lesions

HGD – up to 5%

slide-19
SLIDE 19

Reporting of polyps –

by center

slide-20
SLIDE 20

Reporting of polyps –

by pathologist

slide-21
SLIDE 21

Reporting of polyps –

by pathologist

slide-22
SLIDE 22

Reporting of polyps –

by pathologist

slide-23
SLIDE 23

Serrated polyps 2000-2004

Morphological analysis

and predilection factors of colonic serrated polyps in participants of colon cancer screening programme in years 2000-2004.

slide-24
SLIDE 24

Serrated polyps 2000-2004 2970 SP

1819 MVHP 816 GCHP 249MPHP 58 SSP 28 TSA

slide-25
SLIDE 25

MVHP GCHP MPHP SSP TSA All

Rectum

58,25% 31,38% 9,62% 0,30% 0,44% 1351

Sigmoid colon

62,74% 28,15% 7,27% 1,13% 0,72% 977

Descending colon

62,32% 26,81% 5,80% 2,17% 2,90% 138

Transverse colon

66,83% 17,07% 7,32% 6,83% 1,95% 205

Ascending colon

66,99% 15,53% 7,28% 8,25% 1,94% 206

Cecum

62,37% 13,98% 10,75% 9,68% 3,23% 93

All

1819 (61,25%) 816 (27,24%) 249 (8,38%) 58 (1,95%) 28 (0,94%) 2970 (100%)

slide-26
SLIDE 26

MVHP GCHP MPHP SSP TSA All Rectum

43,27% 51,96% 52,21% 6,90% 21,43% 45,49%

Sigmoid colon

33,70% 33,70% 28,51% 18,97% 25,00% 32,90%

Descending colon

4,73% 4,53% 3,21% 5,17% 14,29% 4,65%

Transverse colon

7,53% 4,29% 6,02% 24,14% 14,29% 6,90%

Ascending colon

7,59% 3,92% 6,02% 29,31% 14,29% 6,94%

Cecum

3,19% 1,59% 4,02% 15,52% 10,71% 3,13%

All

1819 (100%) 816 (100%) 249 (100%) 58 (100%) 28 (100%) 2970 (100%)

slide-27
SLIDE 27

Serrated polyps 2009-2012

slide-28
SLIDE 28

Serrated polyps 2009-2012

slide-29
SLIDE 29

Serrated polyps

Incidence is

variable (2,2-4,8%)

Criteria applied Not restricted to

right bowel

slide-30
SLIDE 30

Trainings for pathologists

Initial training – at the entrance point Ad hoc trainings – upon results of analysis

(HGD, villous component, completeness of excision )

Serrated polyps – unconventional!!! -

international cooperation?

slide-31
SLIDE 31

Why is it crucial?

slide-32
SLIDE 32

Cumulated risk of interval cancer according to ADR

slide-33
SLIDE 33

Most advanced lesion and categorization; incorportation of

histopathological diagnosis in central database

slide-34
SLIDE 34

Most advanced lesion and categorization; incorportation of

histopathological diagnosis in central database

slide-35
SLIDE 35

Summary

High quality pathology is a must Shortage of pathologists Regular trainings Cooperation Most advanced lesion and centralized

histology